ERIN REID: Open Payments
NPI 1669625646 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,233 in 67 payments from 19 companies in 2025. Trend: 2023 $923 · 2024 $1,155 · 2025 $1,233
Food & beverage: $1,233
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $264 |
| AstraZeneca Pharmaceuticals LP | 9 | $148 |
| PFIZER INC. | 5 | $102 |
| Novo Nordisk Inc | 3 | $85 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Astellas Pharma US Inc | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Abbott Laboratories | 2 | $47 |
Products named: QULIPTA, VRAYLAR, REXULTI, NURTEC ODT, Ozempic, Veozah, FARXIGA, Kerendia.
Industry payments across VA — which companies pay providers there.
